RE:FrancoisDThis response may seem obvious, though any developments/news pertaining to the following statement is likely to occur within the next 4-6 months. They will put offering financing to use in various capacities and as this happens they will report on the intent/impact. Again, as I mentioned in my predictions (which I don't think you were directly referring to with this question per say) the timing is the biggest question.
"The net proceeds to the Corporation from the Offering will be used for the advancement of the plasma-derived orphan drug and small molecule therapeutics clinical programs. The net proceeds will also allow the Corporation to exercise greater control and ownership over its technology platforms rather than solely enabling third parties, therefore providing an opportunity to retain a greater portion of the associated value for its shareholders."